The shape, elongation, division and sporulation (SEDS) proteins are a large family of ubiquitous and essential transmembrane enzymes with critical roles in bacterial cell wall biology. The exact function of SEDS proteins was for a long time poorly understood, but recent work 1-3 has revealed that the prototypical SEDS family member RodA is a peptidoglycan polymerase-a role previously attributed exclusively to members of the penicillin-binding protein family 4 . This discovery has made RodA and other SEDS proteins promising targets for the development of next-generation antibiotics. However, little is known regarding the molecular basis of SEDS activity, and no structural data are available for RodA or any homologue thereof. Here we report the crystal structure of Thermus thermophilus RodA at a resolution of 2.9 Å, determined using evolutionary covariance-based fold prediction to enable molecular replacement. The structure reveals a ten-pass transmembrane fold with large extracellular loops, one of which is partially disordered. The protein contains a highly conserved cavity in the transmembrane domain, reminiscent of ligand-binding sites in transmembrane receptors. Mutagenesis experiments in Bacillus subtilis and Escherichia coli show that perturbation of this cavity abolishes RodA function both in vitro and in vivo, indicating that this cavity is catalytically essential. These results provide a framework for understanding bacterial cell wall synthesis and SEDS protein function.
attempted without success. Having exhausted conventional methods, we sought to develop an approach that requires neither experimental phase data nor the structure of a homologous protein.
Recent methodological advances in molecular replacement have expanded the range of suitable templates 8 , and evolutionary co-variation analysis now allows for fold prediction even in the absence of prior structural data [9] [10] [11] . This approach exploits the fact that residues that interact with one another structurally tend to co-evolve to maintain their interactions. The analysis of many sequences enables inference of spatial interactions between pairs of residues, providing restraints sufficient to define major features of protein structure. Analysis of RodA by this method showed extensive co-variation throughout the protein (Fig. 1b, c) , and we reasoned that using evolutionary coupling restraints to build RodA models might provide suitable templates for molecular replacement phasing, an approach we call 'evolutionary coupling-enabled molecular replacement' (EC-MR).
In brief, our EC-MR approach consisted of the parallel construction and sampling of many independent evolutionary coupling-derived models of RodA to identify suitable templates, followed by phase calculation and model building. First, 100 models of RodA were constructed on the basis of evolutionary restraints. These were each tested as single templates for molecular replacement in Phaser 12 . Of these, 22 models yielded a cluster of solutions that were high-scoring and similar to one another ( Fig. 1d ). An ensemble search model was constructed from a subset of these, producing maps that were suitable for manual rebuilding followed by ROSETTA refinement in Phenix 13 . The final refined structure showed normal crystallographic statistics (Extended Data Fig. 1 , Extended Data Table 1 ). While previous work has established that structural models constructed ab initio can in principle be suitable for molecular replacement phasing in select cases 14, 15 , these analyses were conducted on very short proteins (< 100 amino acids) with high-resolution structural data (< 2.1 Å). Other work has shown that at very high resolution, structures can be solved using even a single atom as a search model 16 . At lower resolution, symmetric α -helical proteins can be phased from helical fragments, although this relies on symmetry conditions that are met in only a small minority of cases 17 . Determination of the structure of RodA by EC-MR establishes that evolutionary covariance-derived models can be suitable for phase determination of even a large (359 amino acid) asymmetric protein at modest resolution.
The structures of wild-type RodA and the D255A mutant are virtually identical (Extended Data Fig. 2 ), and we focus here on the higherresolution wild-type RodA structure. The overall structure shows ten well-resolved transmembrane helices (TM1-TM10) connected by loops, most of which are well ordered (Fig. 2) . Searches for proteins of similar fold with the DALI server 18 yielded no hits, indicating that RodA possesses a unique overall fold. The transmembrane helices of RodA are largely straight and perpendicular to the membrane plane, with the exception of TM3 that runs diagonally through the membrane with a 45° kink at Pro71. Although some previous studies have suggested that the SEDS protein FtsW could function as a lipid II flippase 19 , RodA lacks a transmembrane channel suitable for lipid II transport and bears no notable structural similarity to transporters or flippases.
The intracellular loops of RodA are structured but are very short, and little polar surface area is exposed on the intracellular face of the enzyme. By contrast, extracellular loops (ECLs) 2, 4 and 5 are large and contain many functionally essential residues 1 , consistent with catalytic activity occurring at the extracytoplasmic face of the membrane. ECL2 includes a highly conserved β -hairpin, capped by Gly100 and Pro101. ECL4 is even larger at 80 amino acids in length, but is not resolved from residues 189 to 227 as well as from 237 to 251. These regions include essential residues as well as high-ranking evolutionary couplings between ECL4 and ECL1, ECL2 and ECL5, which suggests that they have functionally important roles despite not being resolved in the current structure (Extended Data Figs 3, 4) . It is possible that these regions become ordered only upon substrate binding, or in complex with a peptidoglycan crosslinking enzyme. Unlike other ECLs, ECL5 is not exposed to the surface and instead is buried within the protein core.
Between TM2 and TM3 is a long hydrophobic groove containing electron density suggestive of a bound lipid molecule, which we tentatively modelled as monoolein owing to its high concentration in the crystallization conditions ( Fig. 2b , c, Extended Data Figs 2, 5). This groove is adjacent to a collection of highly conserved residues (Fig. 2c) , and may represent the binding site for the lipid-anchored substrates of RodA. Adjacent to this groove is a large water-filled cavity open to the extracellular face of the protein, flanked by Glu108, Met306, Leu307, Gln310 and Thr342 (Fig. 2d ). On the edge of this cavity, Glu108 and Lys111 form an absolutely conserved salt bridge ( Fig. 2e ). Mapping the results of previous high-throughput mutagenesis in B. subtilis RodA onto the structure shows that the salt bridge and other residues in the central cavity are intolerant of substitution 1 (Fig. 3a) .
To investigate the function of this central cavity in more detail, we turned to site-directed mutagenesis followed by phenotypic characterization in the representative model Gram-negative and Gram-positive organisms E. coli and B. subtilis. First, we assessed whether the conserved salt bridge between Glu108 and Lys111is essential, by monitoring the effect of the mutant enzyme when expressed in a wild-type background. Consistent with previous results, mutation of either of these residues to alanine resulted in a dominant-negative phenotype characteristic of Rod complex dysfunction, in which cells lose their elongated morphology and become enlarged and spherical before lysis (Fig. 3b ). This suggests that the mutant proteins are properly folded and able to interact with other members of the Rod complex, but are unable to promote cell elongation.
To ascertain whether the salt bridge is catalytic or merely important for proper folding, we constructed a salt-bridge swap mutant (that is, an E108K and K111E double mutant). If the role of the salt bridge is purely structural, this swap should have a minimal effect on RodA function, because the salt bridge is maintained. However, if Glu108 has a role in catalysis, then swapping the two amino acids would be expected to abrogate function. Indeed, the mutant protein folds properly as measured by circular dichroism spectroscopy (Extended Data Fig. 6 ), but in cell assays the mutant protein shows a strong dominant-negative phenotype (Fig. 3b , c, Extended Data Fig. 7 ). Moreover, the mutant enzyme has no detectable peptidoglycan polymerization activity in vitro, confirming that its toxicity derives from a lack of catalytic activity ( Fig. 3d , Supplementary Fig. 1 ). Other residues near the central cavity were similarly essential for RodA function, including Asp255 co-evolved residues in RodA. c, Evolutionary couplings (green lines) were used to generate models of RodA. Ten representative models are shown. d, Molecular replacement (MR) solutions obtained from 100 RodA models. As a reference point, the C α atom of Glu108 is shown as a sphere coloured according to loglikelihood gain (LLG) score for each solution. The corresponding position for the final refined RodA structure is shown as a crosshair. The refined structure (green) and the C α atom of Glu108 (magenta sphere) is overlaid with the top MR solutions shown in grey.
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as previously reported 1 , as well as Asp152 (Fig. 3b , Extended Data Fig. 7 ). Analysis of evolutionary co-variation data using EVmutation 20 likewise predicts these residues, and the salt bridge, to be immutable. Taken together, the high degree of sequence conservation, intolerance to mutation and catalytic essentiality of residues surrounding the central cavity confirm that this portion of the protein has a critical role in peptidoglycan polymerization, which makes it a prime target for the development of antibiotics.
The glycan-strand polymerization process catalysed by RodA and aPBPs is essential but not sufficient to build a cell wall. A second key step is peptide crosslinking, catalysed by the penicillin-binding domains of aPBPs and class B penicillin-binding proteins (bPBPs). Cytological and protein-protein interaction studies indicate that SEDS proteins and bPBPs are likely to form a complex in cells 1,2 , and evolutionary coupling analysis shows strong co-variation between bPBP and SEDS protein sequences. This is sufficient to map the binding site between bPBPs and RodA to TM8 and TM9 ( Fig. 4a , b, Extended Data Fig. 8 ), corresponding to the proposed interaction site between the divisome SEDS protein FtsW and its corresponding bPBP, FtsI 10, 21, 22 . RodA mutants in this interface exhibit a dominant-negative effect in E. coli (Fig. 4c ). However, mutation of this site does not prevent RodAmediated peptidoglycan polymerization in vitro (Extended Data Fig. 7 ), confirming the functional importance of coordinated glycan strand elongation and peptide crosslinking in cells.
Complexes between SEDS proteins and bPBPs contain both glycan-strand polymerization and peptide crosslinking active sites, recapitulating the dual catalytic activities found in aPBPs ( Fig. 4d ). Understanding how SEDS proteins coordinate their activity with that of bPBPs to build a cell wall will be an important area for future investigation. The structure of RodA now provides a foundation for such work, serving as a framework for understanding the function of SEDS proteins. Extracytoplasmic   TM1   TM2   TM3   TM4   TM5   TM6   TM7   TM8   TM9  TM10   ECL1   ECL2   ECL3 Viewed from extracytoplasmic side Central cavity 
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No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Protein purification. RodA from T. thermophilus was cloned into pAM172 plasmid 1 using EcoR1 and AvrII restriction enzymes (resulting in plasmids pMS211 and pMS224 for wild-type and D255A RodA, respectively). The expression plasmids contain an amino-terminal SUMO-fusion followed by a Flag epitope tag and a 3C protease cleavage site (SUMO-Flag-3C-RodA and SUMO-Flag-3C-RodA(D255A)), and were transformed into E. coli C43 derivative of BL21 (DE3) harbouring an arabinose-inducible Ulp1 protease plasmid (pAM174) under the selection for both plasmids. Five fresh transformants harbouring both plasmids were inoculated into 5 ml LB medium supplemented with 100 μ g ml −1 ampicillin and 35 μ g ml −1 chloramphenicol and allowed to grow overnight at 37 °C in a rolling shaker. The 5-ml overnight culture was then diluted in 1 litre of TB broth supplemented with 0.1% glucose, 2 mM MgCl 2 , 100 μ g ml −1 ampicillin, and 35 μ g ml −1 chloramphenicol. Cultures were grown at 37 °C until an OD 600 of 0.6 and shifted to 20 °C. At an OD 600 of 0.8, protein expression was induced by addition of IPTG (1 mM final) and arabinose (0.2% final) for RodA and Ulp1, respectively. After a 16-h induction, cells were collected and frozen at − 80 °C.
Cells were resuspended in lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 20 mM MgCl 2 , 100 μ g ml −1 lysozyme, 1:100,000 (v/v) benzonase nuclease, and 2 mg ml −1 iodoacetamide), lysed by sonication and membranes were collected by ultracentrifugation at 100,000g for 1 h at 4 °C. Flag-3C-RodA was then extracted using a glass dounce tissue grinder in a solubilization buffer containing 20 mM HEPES pH 7.5, 500 mM NaCl, 20% (v/v) glycerol, 2 mg ml −1 iodoacetamide, and 1% (w/v) N-dodecyl β -d-maltoside (DDM; Anatrace). Samples were stirred for 2 h at 4 °C, then centrifuged as above for 1 h. The supernatant containing solubilized RodA was supplemented with 2 mM CaCl 2 and loaded by gravity flow onto 4 ml anti-Flag antibody affinity resin. The resin was washed extensively, first in 50 ml of buffer containing 20 mM HEPES pH 7.0, 500 mM NaCl, 2 mM CaCl 2 , 20% glycerol, 0.1% DDM, and then in 50 ml of the same buffer supplemented with 10 mM adenosine 5′ -triphosphate magnesium salt and 20 mM KCl to remove the bacterial chaperones, GroEL and DnaK. RodA was eluted in 20 mM HEPES pH 7.0, 500 mM NaCl, 20% glycerol, 0.1% DDM supplemented with 5 mM EDTA and 0.2 mg ml −1 Flag peptide. 3C protease was added (1:1,000 w/w) and incubated with RodA at 4 °C overnight. RodA was further purified by size exclusion chromatography (SEC) on a Sephadex S200 column (GE Healthcare) in buffer containing 20 mM HEPES pH 7.5, 500 mM NaCl and 0.1% DDM. After preparative SEC, the protein was concentrated to 30-40 mg ml −1 and flash-frozen with liquid nitrogen in aliquots of 8 μ l. Samples were stored at − 80 °C until use for crystallography. Purity and monodispersity of crystallographic samples was evaluated by SDS-PAGE and analytical SEC, respectively. Crystallography and data collection. Purified T. thermophilus wild-type and D255A RodA were reconstituted into lipidic cubic phase by mixing with a 10:1 (w/w) mix of monoolein (Hampton Research) with cholesterol (Sigma Aldrich) at a ratio of 1.0:1.5 protein:lipid by mass, using the coupled syringe reconstitution method 23 . All samples were mixed at least 100 times before dispensing. The resulting phase was dispensed in 15-40 nl drops onto a glass plate and overlaid with 600 nl of precipitant solution using a Gryphon LCP robot (Art Robbins Instruments). Crystals grew in precipitant solution containing 35-50% PEG 200, 100 mM NaCl, 100 mM MgCl 2 and 100 mM Tris pH 7.6-8.2. Initial crystallization hits grew within 24 h, with diffraction-quality crystals reaching full size over the course of 2-4 weeks. Crystals were collected using mesh loops and stored in liquid nitrogen until data collection. Data collection was carried out at Advanced Photon Source GM/CA beamline 23ID-B. An initial grid raster with 80 × 30-μ m beam dimensions was performed to locate crystals within the loop. Additional fine-tuning rasters were performed using a 10-μ m beam diameter to optimize the position of the crystal for data collection. Data were collected using a 10-μ m beam and 0.2°-oscillation width per frame at a wavelength of 1.033 Å and a fivefold attenuation factor. For both wild-type and D255A RodA, a complete dataset was obtained from a single crystal. Diffraction data were indexed and processed using XDS 24 . Both wild-type and D255A RodA crystallized in the C2 space group with one molecule in the asymmetric unit, with a solvent content of approximately 60%. Generation of ab initio evolutionary coupling-derived models of RodA. Multiple sequence alignments (MSA) of the full length T. thermophilus RodA (Uniprot ID Q5SIX3) were generated using the iterative hidden Markov model-based sequence search tool jackhmmer 25 with five iterations. Alignments were built using the Uniref100 dataset 26 released in April 2017. An MSA was generated for nine different bitscores, a sequence inclusion threshold was normalized to length and expressed as the number of bits per residue, with values ranging from the most inclusive (0.1) to the least inclusive (0.9). The alignment depth was chosen to optimize the number of non-redundant sequences with the fewest gaps in the alignment as previously described 9,10 , although the alignment choice was robust with respect to consistency of predicted evolutionary couplings over a wide range of alignment depths. Blindly optimizing the alignment choice resulted in two alignments, with the smaller one at 31,505 non-redundant sequences of length-346 residues (10-355) and an 'effective number' of 8,729 sequences after downweighting sequences with more than 80% identity and no more than 30% gaps in any columns used for the EC model computation. Model folding criteria. For the chosen MSAs, evolutionary couplings were determined using a pseudo-likelihood maximization (PLMC) [27] [28] [29] . A mixture model approach identified the 99% percentile probability of being in contact. We used a combination of commonly used prediction methods to determine secondary structure predictions (PSIPRED 30 and PolyPhobius 31 ), together with secondary structure propensity computed directly from local evolutionary couplings 29 . This resulted in the identification of ten transmembrane helices and three smaller helices in ECL4, and two β -strands in ECL2. A total of 220 folded models for T. thermophilus RodA were generated for increasing numbers of evolutionary coupling restraints using the folding protocol in EVfold 9 , which uses a distance geometry and simulated annealing protocol in CNS 32, 33 . All models were ranked as previously described 11, 34 and the 50 top-ranked models from each of the MSAs were used as molecular replacement search models (see below). To generate additional models used for further ensemble-based phasing runs, five additional models were generated using the top-ranked fold prediction from bitscore 0.8 with an additional round of dedicated simulated annealing in CNS. Cartesian dynamics were used for heating, torsion for cooling and 600 final minimization steps with 50 cycles were used with other parameters kept as defaults. In addition to evolutionary couplings scores, for folded models EVfold generates an evolutionary coupling enrichment score for each residue that reflects how constrained that residue is, which can be thought of as conservation of 'coupling' . Phasing and refinement. One hundred evolutionary coupling-derived models of wild-type RodA were primed for molecular replacement using Sculptor 35 , which included limited side-chain pruning and B-factor assignment based on accessible surface area 36 . Each model was tested as a single search template for molecular replacement in Phaser 12 , resulting in 98 out of the 100 initial models providing candidate solutions. The solutions were sorted by translation function Z-score (TF-Z) and the top 32 solutions manually inspected in PyMOL 37 . A total of 22 solutions were highly similar and distinct from all other solutions. Sorting the solutions by log-likelihood gain (LLG) provided a similar result, in which all 22 solutions were among the top 40% of solutions. However, most of these were not well separated from other potential solutions in their respective searches, typically with two-to-four other candidate solutions giving LLG values at least 75% of that of the top solution. The models giving the top two solutions (as judged by both TF-Z and LLG metrics) were used as a single ensemble for phase calculation followed by manual building using COOT 38 and reciprocal space refinement using phenix.refine 39 . Manual refinement was complemented by the use of ROSETTA refinement in Phenix 13 . Subsequently, additional cycles of manual building and reciprocal space refinement led to the final refined structure.
Verification of sequence register was straightforward and unambiguous owing to the relatively high resolution and frequency of bulky amino acid side chains (RodA is roughly 10% tryptophan, tyrosine and phenylalanine). Representative composite omit map density is shown in Extended Data Fig. 1 . The structure of RodA(D255A) was solved using wild-type RodA as the molecular replacement search model and the resulting refined structure is nearly identical to that of wildtype RodA (0.1 Å r.m.s.d. between all C α atoms). After refinement, the quality of both structures was assessed using MolProbity to calculate Ramachandran statistics and other parameters 40 , and figures were prepared in PyMOL. All crystallographic data processing, refinement and analysis software was compiled and supported by the SBGrid Consortium 41 . Predicting residue contacts between RodA and PBP2. EVComplex 10 was used to predict inter-protein contacts between T. thermophilus full-length RodA and full-length PBP2 (Uniprot ID Q5SJ23). We constructed alignments for RodA (33,670 sequences) and PBP2 (40,764 sequences) as described above for RodA alone, using the April 2017 Uniprot release 42 for clarity on species identifiers. We concatenated RodA and PBP2A sequences from each species when they were within 10,000 nucleotides of each other, based on European Nucleotide Archive data downloaded in February 2017 43 , and evolutionary couplings were computed on the complex alignment as previously described 10 . A mixture model approach was used to identify top-scoring contacts, both within individual monomers and between RodA and PBP2, and to assign a probability to each contact of being within the tail of the distribution of coupling scores as previously described 29 . This scoring method is accurate for predicting whether proteins interact as well as which residues are in contact 10 . The distribution of evolutionary couplings is approximated by a Gaussian log-normal mixture model, and we defined the tail of the distribution as those scores that have > 95% probability of belonging to the log-normal component. Evolutionary couplings in this tail defined as high probability resulted in 26 residue pairs predicted as contacts between RodA and PBP2. Sequence and structure conservation analysis. The sequence conservation analysis shown in Fig. 3 and Extended Data Fig. 5 was computed using the ConSurf server 44 . In brief, a multiple sequence alignment of T. thermophilus RodA to its closest 150 homologues was generated using the HHMER algorithm provided by ConSurf, with conservation scores plotted in PyMOL. Additionally, a multiple sequence alignment of RodA to 506 homologues from representative bacterial taxa was generated using a protein sequence BLAST search on the NCBI public database using T. thermophilus RodA protein sequence as query, and plotted in Extended Data Fig. 3 . Homology modelling and mutability index. A homology model of B. subtilis RodA based on the structure of T. thermophilus RodA was constructed using MODELLER 45 . In brief, owing to the low sequence identity (~ 26%) between the two enzymes, a multiple sequence alignment of 10 RodA homologues from diverse bacterial taxa was performed (T. thermophilus, B. subtilis, E. coli, Staphylococcus aureus, Streptococcus pneumoniae, Shigella flexneri, Haemophilus influenzae, Deinococcus marmoris, Bacillus safensis and Lysinibacillus odysseyi). The resulting alignment was used as the search template in MODELLER, in which disordered residues 204-256 and 266-276 were omitted from the model generation. A total of ten models were generated and the top-scoring model was chosen for further analysis.
The mutability index of each residue in the homology model of B. subtilis RodA was calculated based on previously reported MutSeq data 1 . First, for each residue the nonsynonymous mutation rate was defined as the number of mutations observed after excluding synonymous and nonsense mutations. To calculate a raw mutability index, the nonsynonymous mutation rate was divided by the summed rate of silent mutations observed for a given nucleotide position. Finally, the raw mutability index for each residue was normalized with respect to the expected silent mutation rate for each general class of nucleotide change, resulting in a per cent mutability index for each residue. A low mutability index (that is, low percentage) represents a residue that is relatively intolerant of mutation at that position and a high mutability index (high percentage) represents a residue that is relatively tolerant of changes at that position. RodA mutant plasmid and strain construction. Mutants of E. coli RodA were introduced using QuikChange mutagenesis into a plasmid containing the allele P lac -pbpA-rodA(WT) (pHC857) 1,2 . Wild-type E.coli cells (strain TB28) were then transformed with the mutant plasmids to generate strains that each harboured mutations in the central cavity (E114A, K117A, E114K/K117E and D159A) and at the RodA-PBP2 interface (L240S, S326A and L281A).
Mutations of B. subtilis RodA were introduced using QuikChange mutagenesis into the pER174a plasmid (amyE::P xyl -rodA(WT)-10×His) 1 . The resulting mutagenic plasmids (amyE::P xyl -rodA(allele)-10×His) was directly transformed into the B. subtilis strain (rodA::kan, P spank -rodA(WT)-10×His, and P pen sacA::mCherry) to generate strains each harbouring mutations in the central cavity (Q114A, E117A, K120A, E117K/K120E, D280N and S364A), the proposed lipid-binding cavities (I113A, I113S, and F118A and A171L), and the RodA-PBP2 interface (F292A). The B. subtilis strains harbouring amyE::P xyl -rodA-(D167A), amyE::P xyl -rodA(D167N), and amyE::P xyl -rodA(D280A) have previously been described 1 . Mutational analysis in vivo. All E. coli cultures were grown at 37 °C in M9 minimal medium supplemented with 0.2% (w/v) maltose, 0.2% (w/v) casamino acids, and 25 μ g ml −1 chloramphenicol. Overnight cultures were diluted to an OD 600 of 0.05 and grown to OD 600 = 0.25 in the absence of inducer. These cultures were then further diluted to an OD 600 of 0.005 in medium containing 1 mM IPTG to induce expression of the pbpA-rodA construct. Cells were grown for five generations in the presence of inducer and fixed when the OD 600 reached between 0.15 and 0.2. Fixative solution contained 0.04% glutaraldehyde, 4% formaldehyde, 32 mM sodium phosphate, pH 7.5. Wide-field phase-contrast microscopy was performed on a Nikon TE2000 microscope equipped with a 100× Plan Apo 1.4 NA objective and a CoolSNAP HQ2 monochrome camera.
B. subtilis strains were derived from the PY79 prototrophic strain 46 . Cells were grown in LB medium at 37 °C in the presence of 10 μ M IPTG to express wild-type RodA. When cultures reached mid-log, cells were washed three times with plain LB medium and resuspended in 20 ml of LB medium to an OD 600 of 0.02, then supplemented with 10 mM xylose to induce expression of RodA wild type and variants. Cells were analysed by phase-contrast microscopy 90 min later. Microscopy was performed on a Nikon Ti microscope equipped with Plan Apo 100× /1.4NA phase-contrast oil objective and a CoolSNAP HQ2 camera. Cells were immobilized using 2% agarose pads, containing growth medium. Images were cropped and adjusted using MetaMorph software (Molecular Devices). Mutant analysis in vitro. Mutants of B. subtilis RodA were transformed into E. coli strain CAM333, a derivative of strain C43 with deletions in ponB, pbpC and mgtA, and were expressed and purified by immunoaffinity chromatography as previously described 1 .
Before circular dichroism spectroscopy experiments, each RodA mutant was dialysed into a buffer consisting of 10 mM sodium phosphate pH 7.5, 500 mM potassium fluoride, 0.5% (w/v) CHAPS, and 0.05% (w/v) DDM. Spectra were acquired on a Jasco J-815 spectropolarimeter. Circular dichroic spectra were recorded between 200-260 nm using a quartz cuvette with a path length of 1 mm, a 50-nm/min scanning speed, and a bandwidth of 1 nm. Five spectra were measured at 25 °C, averaged and corrected for buffer contribution. Secondary structure assessment was not performed owing to high absorbance contributions at wavelengths less than 205 nm from the detergent mixture necessary for protein stability and function (0.5% CHAPS, 0.05% DDM).
For assessment of enzymatic activity, lipid II substrate was purified from E. coli as described 47 . Peptidoglycan polymerization reactions were adapted from previously described methods 48 . In brief, purified B. subtilis wild-type and mutant RodA proteins were incubated with lipid II in reaction buffer containing 50 mM HEPES pH 7.0, 20 mM CaCl 2 , 20 mM MgCl 2 and 20% DMSO. The working concentration of RodA and lipid II were 1 μ M and 20 μ M, respectively. RodA was purified in 0.5% CHAPS and 0.05% DDM, and therefore the working concentration for CHAPS and DDM was 0.05% and 0.005%, respectively. As a positive control lipid II was also polymerized with SgtB(Y181D) (1 μ M) in reaction buffer containing 12.5 mM HEPES pH 7.5, 2 mM MnCl 2 , 0.25 mM Tween-80 and 20% DMSO. All reactions were incubated at 25 °C for 1 h and quenched by incubation at 95 °C for 2 min. Peptidoglycan biotinylation of each reaction mixture was performed by addition of biotinylated d-lysine (1.5 mM, final concentration) and PBP4 (3.8 μ M, final concentration) followed by incubation at 25 °C for 1 h. The biotinylation reaction was then quenched by addition of 13 μ l 2× SDS loading dye. The samples were then loaded into a 4-20% gradient polyacrylamide gel and run at 180 V. The products were transferred onto a PVDF membrane (BioRad) and fixed in 0.4% paraformaldehyde diluted in PBS for 30 min at room temperature. The membrane was blocked with SuperBlock TBS blocking buffer (Thermo Fisher Scientific) for 1 h at room temperature and the biotinylated products were detected by incubation with fluorescently tagged streptavidin (IRDye 800-CW streptavidin (Li-Cor Biosciences, 1:5,000 in SuperBlock)) for an additional 30 min. Membranes were washed 4 × 10 min with TBST (0.01% Tween 20) and given a final 10-min wash in PBS. Blots were then visualized using an Odyssey CLx imaging system (LI-COR Biosciences). Code availability. The full EVfold software package is available at https://github. com/debbiemarkslab/EVcouplings. Data availability. Structure factors and refined atomic coordinates for RodA wild type and the RodA(D255A) mutant are deposited in the RCSB Protein Data Bank under accession codes 6BAR and 6BAS, respectively.
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Extended Data Figure 4 | RodA evolutionary couplings. a, The refined crystal structure of T. thermophilus RodA (shown in light blue) is in close agreement with its evolutionary couplings. Green, yellow and red lines between residues represent regions of the structure that are less than 5 Å, between 5 and 10 Å, and greater than 10 Å of the predicted evolutionary couplings, respectively. b, The partially disordered ECL4 in the refined structure is strongly coupled evolutionarily to the transmembrane domain of RodA. A representation of predicted intra-and inter-domain evolutionary couplings for ECL4 is mapped onto a EVfold model (shown in grey). For each panel, the circular dichroic spectra of wild-type and the indicated mutant RodA are shown in black and blue, respectively. The corresponding T. thermophilus numbering for each mutant is shown in parentheses. Experiments were repeated independently twice with similar results. Corresponding author(s): Andrew C. Kruse
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